Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
February 21, 2024 08:00 ET
|
Vaccinex, Inc.
Eight new antibody discovery agreements incorporate Vaccinex’s powerful ActivMAb® Drug Discovery Platform ActivMab® platform enables the discovery and development of high value antibodies against...
Pharmaceutical Chemicals Market Size to be Worth USD 339.3 billion by 2031, with a Projected CAGR of 5.8%| Says Transparency Market Research, Inc.
January 15, 2024 02:44 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The pharmaceutical chemicals market was valued at US$ 204.3 billion in 2022. From 2023 to...
ME2C® Environmental Announces Preliminary 2022 Revenue Guidance and Outlines Key Priorities and Milestones for 2022
February 16, 2022 08:30 ET
|
Midwest Energy Emissions Corp.
Preliminary Revenue Expected to Increase At Least 60% Year-Over-Year for 2022Company Reviews Key Business Highlights Achieved In 2021 CORSICANA, TX, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Midwest Energy...
CareCloud Declares Dividends on Non-Convertible Series A Cumulative Redeemable Perpetual Preferred Stock
August 06, 2021 09:25 ET
|
CareCloud, Inc
SOMERSET, N.J., Aug. 06, 2021 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services,...
REPEAT - Pure Extracts Orders Over 30,000 Vape Cartridges in Preparation for Retail Distribution
March 03, 2021 09:00 ET
|
Pure Extracts Technologies Corp.
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction...
Pure Extracts Orders Over 30,000 Vape Cartridges in Preparation for Retail Distribution
March 03, 2021 00:05 ET
|
Pure Extracts Technologies Corp.
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction...
MTBC Announces Results from Annual Shareholder Meeting
June 25, 2019 09:00 ET
|
MTBC
SOMERSET, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based healthcare IT and practice management solutions, today...
Emerald Joint Venture Receives Licenses from Health Canada to Sell Proprietary Products Supporting the Endocannabinoid System
December 04, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
Endo Brain recently awarded 2018 SupplySide Editor’s Choice Award for Brain Health Planned mid-2019 product launch will open natural health product, grocery, and pharmacy store channels to Emerald...
Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products
October 03, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) has entered into a research agreement with VivaCell...
MTBC Partners with Pikeville Medical Center on 2018 East Kentucky Heart Ball
February 13, 2018 09:32 ET
|
MTBC
SOMERSET, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based electronic health records, practice management and mHealth...